We have done more than 4.00 Lakh COVID-19 RT-PCR tests and more than 3.20 Lakh COVID antibody tests as on 30.09.2020. While we have enhanced the capacity to do 400 RT-PCR tests per hour we have got approvals for new facility at Gurgaon Delhi by NABL. It is also built with an ability to do 400 tests per hour. We are also creating facilities for COVID testing in Bangalore and Kolkata to meet the expected demand.
Q2 of FY 21 has seen a motivating numbers and increased turnover of COVID PCR and COVID Antibody testing and the revenue for Sept. 2020 quarter has increased by 37% compared to Q2 of FY 20. The low revenue in Q1 of FY 21 has bounced back in Q2 of FY 21 with a growth of 171% over previous quarter. The financial statements Sept. 2020 quarter are under review by our statutory auditors and we will file our financial release post approval by Audit Committee and Board. Meanwhile we are filing this update to keep the shareholders / stakeholders informed of the business status.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
